NeurOP's Grant

NeurOP raised a round of funding on April 11, 2012. Investors include National Institutes of Health.

NeurOp is a biopharmaceutical company developing new medicines to treat central nervous system disorders, including major depression, neuropathic pain and ischemia. The company's mission is to develop…

Articles about NeurOP's Grant: